Table 1.
Patient Characteristics at Baseline (n=43)
| Characteristic | |
|---|---|
| Age, years | 37.5 (30.7, 44.5) |
| Male, n (%) | 33 (77%) |
| Black race, n (%) | 24 (57%) |
| Ever smoked, n (%) | 31 (72%) |
| Smoking amount, pack per day years | 3.9 (0, 9.1) |
| ≤ High school graduate/GED, n (%) | 21 (49%) |
| Medicaid/care or Ryan White insurance, n (%) | 30 (70%) |
| Hypertension medication, n (%) | 6 (14%) |
| Months on HAART | 2.5 (1.1, 7.3) |
| Family history of CVD, n (%) | 9 (21%) |
| Months since first HIV-positive test | 25.0 (11.7, 77.1) |
| CD4+ T cell count (cells/μl) | 363 (207, 453) |
| Plasma HIV RNA level (copies/ml) | 1059 (60, 31017) |
| Nadir CD4+ T cell count (cells/μl) | 230 (135, 305) |
| Months since nadir CD4 | 5.1 (1.8, 9.5) |
Data are shown as median (first and third quartiles), unless otherwise specified.
HAART, highly active antiretroviral therapy; CVD, cardiovascular disease.